Gilead Sciences Officer Johanna Mercier Files Form 144 to Sell $432K in Common Stock
GILEAD SCIENCES, INC.
Subscribe to track GILD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Form 144 Filing Alert: Gilead Sciences, Inc. ($GILD) • Insider: Johanna Mercier (Officer) • Proposed Sale: 3,000 Common Shares • Estimated Market Value: $432,646.20 (~$144.22/share) • Broker: Morgan Stanley Smith Barney LLC • Plan Date: Rule 10b5-1 plan adopted on 02/20/2025 • Filing Date: September 15, 2026
Comprehensive Analysis
Executive Summary
On September 15, 2026, Johanna Mercier, an Officer at Gilead Sciences, Inc. ($GILD), filed a Form 144 notice of proposed sale for 3,000 shares of common stock through Morgan Stanley Smith Barney LLC. The aggregate market value of the proposed transaction is approximately $432,646.20, representing an estimated price of $144.22 per share.
Transaction & Acquisition Details
- Securities to be Sold: 3,000 shares of Common Stock.
- Origin of Shares: Acquired on February 4, 2025, as Performance Shares directly from the issuer.
- Trading Plan: Executed pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
- Prior 3-Month Sales:
- August 17, 2026: Sold 28,000 shares for gross proceeds of $3,853,907.85.
- July 15, 2026: Sold 3,000 shares for gross proceeds of $389,757.60.
Market Impact & Significance
The trading significance is rated Low. The proposed sale represents a negligible fraction of Gilead's outstanding common stock (over 1.23 billion shares outstanding) and is carried out under a pre-established Rule 10b5-1 trading plan.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.